J Korean Neurosurg Soc.  2019 Jan;62(1):10-26. 10.3340/jkns.2018.0180.

Magnetic Resonance-Guided Focused Ultrasound : Current Status and Future Perspectives in Thermal Ablation and Blood-Brain Barrier Opening

• Lee EJ
• Fomenko A
• Lozano AM

• KMID: 2434342
• DOI: http://doi.org/10.3340/jkns.2018.0180

Abstract

Magnetic resonance-guided focused ultrasound (MRgFUS) is an emerging new technology with considerable potential to treat various neurological diseases. With refinement of ultrasound transducer technology and integration with magnetic resonance imaging guidance, transcranial sonication of precise cerebral targets has become a therapeutic option. Intensity is a key determinant of ultrasound effects. High-intensity focused ultrasound can produce targeted lesions via thermal ablation of tissue. MRgFUS-mediated stereotactic ablation is non-invasive, incision-free, and confers immediate therapeutic effects. Since the US Food and Drug Administration approval of MRgFUS in 2016 for unilateral thalamotomy in medication-refractory essential tremor, studies on novel indications such as Parkinson's disease, psychiatric disease, and brain tumors are underway. MRgFUS is also used in the context of blood-brain barrier (BBB) opening at low intensities, in combination with intravenously-administered microbubbles. Preclinical studies show that MRgFUS-mediated BBB opening safely enhances the delivery of targeted chemotherapeutic agents to the brain and improves tumor control as well as survival. In addition, BBB opening has been shown to activate the innate immune system in animal models of Alzheimer's disease. Amyloid plaque clearance and promotion of neurogenesis in these studies suggest that MRgFUS-mediated BBB opening may be a new paradigm for neurodegenerative disease treatment in the future. Here, we review the current status of preclinical and clinical trials of MRgFUS-mediated thermal ablation and BBB opening, described their mechanisms of action, and discuss future prospects.

Keyword

Alzheimer disease; Blood-brain barrier; Essential tremor; High-intensity focused ultrasound ablation

MeSH Terms

Alzheimer Disease
Blood-Brain Barrier*
Brain
Brain Neoplasms
Essential Tremor
High-Intensity Focused Ultrasound Ablation
Immune System
Magnetic Resonance Imaging
Microbubbles
Models, Animal
Neurodegenerative Diseases
Neurogenesis
Parkinson Disease
Plaque, Amyloid
Sonication
Therapeutic Uses
Transducers
Ultrasonography*
United States Food and Drug Administration
Therapeutic Uses

Figure

• 

  Fig. 1. Schematic depicting proposed pulsed LIFU neuromodulation mechanism. A : Resting state of neuron without ultrasound. B : Depolarized state with ultrasound. The mechanical force of ultrasound wave changes neuronal lipid bilayers tension. Voltage-gated ion channels, including Na+ , Ca2+, and K+ channels, with mechanosensitive properties, open in response to pulsed LIFU, which leads to depolarization and generation of action potentials, eventually stimulating neurons. Here, Na+ channels are depicted as an example. LIFU : low-intensity focused ultrasound.

• 

  Fig. 2. Schematic illustration of transient BBB opening. MRgFUS in conjunction with microbubbles leads to open the BBB by separating the endothelial tight junction, allowing enhanced delivery of therapeutic agents. BBB : blood-brain barrier, MRgFUS : magnetic resonance-guided focused ultrasound.

• 

  Fig. 3. A : Schematic illustration of stable cavitation. As the acoustic wave propagates longitudinally, it alternates between compression and expansion, with changing acoustic pressures along the sinusoidal curve. When microbubbles are subjected to pressures below the inertial cavitation threshold, they contract during compression and expand during rarefaction, resulting in stable oscillation. B : With ultrasonic pressure above the inertial cavitation threshold, microbubbles initially oscillate but eventually implode at rarefaction pressure.

Reference

References

1. Adrianov OS, Vykhodtseva NI, Fokin VF, Uranova NA, Avirom VM. Reversible functional shutdown of the optic tract on exposure to focused ultrasound. Biull Eksp Biol Med. 97:760–762. 1984.

2. Alkins R, Burgess A, Ganguly M, Francia G, Kerbel R, Wels WS, et al. Focused ultrasound delivers targeted immune cells to metastatic brain tumors. Cancer Res. 73:1892–1899. 2013.

3. Alkins R, Burgess A, Kerbel R, Wels WS, Hynynen K. Early treatment of HER2-amplified brain tumors with targeted NK-92 cells and focused ultrasound improves survival. Neuro Oncol. 18:974–981. 2016.

4. Alkins R, Huang Y, Pajek D, Hynynen K. Cavitation-based third ventriculostomy using MRI-guided focused ultrasound. J Neurosurg. 119:1520–1529. 2013.

5. Alomar S, King NK, Tam J, Bari AA, Hamani C, Lozano AM. Speech and language adverse effects after thalamotomy and deep brain stimulation in patients with movement disorders: a meta-analysis. Mov Disord. 32:53–63. 2017.

6. Alvarez L, Macias R, Pavón N, López G, Rodríguez-Oroz MC, Rodríguez R, et al. Therapeutic efficacy of unilateral subthalamotomy in Parkinson’s disease: results in 89 patients followed for up to 36 months. J Neurol Neurosurg Psychiatry. 80:979–985. 2009.

7. Alvarez M, Paull K, Monks A, Hose C, Lee JS, Weinstein J, et al. Generation of a drug resistance profile by quantitation of mdr-1/P-glycoprotein in the cell lines of the National Cancer Institute Anticancer Drug Screen. J Clin Invest. 95:2205–2214. 1995.

8. Aryal M, Vykhodtseva N, Zhang YZ, Park J, McDannold N. Multiple treatments with liposomal doxorubicin and ultrasound-induced disruption of blood-tumor and blood-brain barriers improve outcomes in a rat glioma model. J Control Release. 169:103–111. 2013.

9. Beaumont TL, Mohammadi AM, Kim AH, Barnett GH, Leuthardt EC. Magnetic resonance imaging-guided laser interstitial thermal therapy for glioblastoma of the corpus callosum. Neurosurgery. 83:556–565. 2018.

10. Bond AE, Shah BB, Huss DS, Dallapiazza RF, Warren A, Harrison MB, et al. Safety and efficacy of focused ultrasound thalamotomy for patients with medication-refractory, tremor-dominant parkinson disease: a randomized clinical trial. JAMA Neurol. 74:1412–1418. 2017.

11. Borrelli MJ, Bailey KI, Dunn F. Early ultrasonic effects upon mammalian CNS structures (chemical synapses). J Acoust Soc Am. 69:1514–1516. 1981.

12. Burgess A, Dubey S, Yeung S, Hough O, Eterman N, Aubert I, et al. Alzheimer disease in a mouse model: MR imaging-guided focused ultrasound targeted to the hippocampus opens the blood-brain barrier and improves pathologic abnormalities and behavior. Radiology. 273:736–745. 2014.

13. Burgess A, Huang Y, Querbes W, Sah DW, Hynynen K. Focused ultrasound for targeted delivery of siRNA and efficient knockdown of Htt expression. J Control Release. 163:125–129. 2012.

14. Burgess A, Shah K, Hough O, Hynynen K. Focused ultrasound-mediated drug delivery through the blood-brain barrier. Expert Rev Neurother. 15:477–491. 2015.

15. Bystritsky A, Korb AS, Douglas PK, Cohen MS, Melega WP, Mulgaonkar AP, et al. A review of low-intensity focused ultrasound pulsation. Brain Stimul. 4:125–136. 2011.

16. Cao L, Jiao X, Zuzga DS, Liu Y, Fong DM, Young D, et al. VEGF links hippocampal activity with neurogenesis, learning and memory. Nat Genet. 36:827–835. 2004.

17. Carpentier A, Canney M, Vignot A, Reina V, Beccaria K, Horodyckid C, et al. Clinical trial of blood-brain barrier disruption by pulsed ultrasound. Sci Transl Med. 8 :343re342:2016.

18. Chang EL, Ting CY, Hsu PH, Lin YC, Liao EC, Huang CY, et al. Angiogenesis-targeting microbubbles combined with ultrasound-mediated gene therapy in brain tumors. J Control Release. 255:164–175. 2017.

19. Chang JW, Park CK, Lipsman N, Schwartz ML, Ghanouni P, Henderson JM, et al. A prospective trial of magnetic resonance-guided focused ultrasound thalamotomy for essential tremor: results at the 2-year followup. Ann Neurol. 83:107–114. 2018.

20. Chang WS, Jung HH, Kweon EJ, Zadicario E, Rachmilevitch I, Chang JW. Unilateral magnetic resonance guided focused ultrasound thalamotomy for essential tremor: practices and clinicoradiological outcomes. J Neurol Neurosurg Psychiatry. 86:257–264. 2015.

21. Chang WS, Jung HH, Zadicario E, Rachmilevitch I, Tlusty T, Vitek S, et al. Factors associated with successful magnetic resonance-guided focused ultrasound treatment: efficiency of acoustic energy delivery through the skull. J Neurosurg. 124:411–416. 2016.

22. Chen H, Konofagou EE. The size of blood-brain barrier opening induced by focused ultrasound is dictated by the acoustic pressure. J Cereb Blood Flow Metab. 34:1197–1204. 2014.

23. Chen PY, Liu HL, Hua MY, Yang HW, Huang CY, Chu PC, et al. Novel magnetic/ultrasound focusing system enhances nanoparticle drug delivery for glioma treatment. Neuro Oncol. 12:1050–1060. 2010.

24. Chen PY, Wei KC, Liu HL. Neural immune modulation and immunotherapy assisted by focused ultrasound induced blood-brain barrier opening. Hum Vaccin Immunother. 11:2682–2687. 2015.

25. Christmas D, Eljamel MS, Butler S, Hazari H, MacVicar R, Steele JD, et al. Long term outcome of thermal anterior capsulotomy for chronic, treatment refractory depression. J Neurol Neurosurg Psychiatry. 82:594–600. 2011.

26. Clement GT, White PJ, King RL, McDannold N, Hynynen K. A magnetic resonance imaging-compatible, large-scale array for trans-skull ultrasound surgery and therapy. J Ultrasound Med. 24:1117–1125. 2005.

27. Coluccia D, Fandino J, Schwyzer L, O’Gorman R, Remonda L, Anon J, et al. First noninvasive thermal ablation of a brain tumor with MR-guided focused ultrasound. J Ther Ultrasound. 2:17. 2014.

28. Dalecki D. Mechanical bioeffects of ultrasound. Annu Rev Biomed Eng. 6:229–248. 2004.

29. Dallapiazza RF, Timbie K, Elias WJ. Innovative Neuromodulation: Ultrasound Neuromodulation, ed 1. Cambridge: Academic Press;2017. p. p102.

30. Davson H. Review lecture. The blood-brain barrier. J Physiol. 255:1–28. 1976.

31. DiFiglia M, Sena-Esteves M, Chase K, Sapp E, Pfister E, Sass M, et al. Therapeutic silencing of mutant huntingtin with siRNA attenuates striatal and cortical neuropathology and behavioral deficits. Proc Natl Acad Sci U S A. 104:17204–17209. 2007.

32. Dinno MA, Dyson M, Young SR, Mortimer AJ, Hart J, Crum LA. The significance of membrane changes in the safe and effective use of therapeutic and diagnostic ultrasound. Phys Med Biol. 34:1543–1552. 1989.

33. Duck FA. Medical and non-medical protection standards for ultrasound and infrasound. Prog Biophys Mol Biol. 93:176–191. 2007.

34. Elias WJ, Huss D, Voss T, Loomba J, Khaled M, Zadicario E, et al. A pilot study of focused ultrasound thalamotomy for essential tremor. N Engl J Med. 369:640–648. 2013.

35. Elias WJ, Lipsman N, Ondo WG, Ghanouni P, Kim YG, Lee W, et al. A randomized trial of focused ultrasound thalamotomy for essential tremor. N Engl J Med. 375:730–739. 2016.

36. Etame AB, Diaz RJ, Smith CA, Mainprize TG, Hynynen K, Rutka JT. Focused ultrasound disruption of the blood-brain barrier: a new frontier for therapeutic delivery in molecular neurooncology. Neurosurg Focus. 32:E3. 2012.

37. Fasano A, Llinas M, Munhoz RP, Hlasny E, Kucharczyk W, Lozano AM. MRI-guided focused ultrasound thalamotomy in non-ET tremor syndromes. Neurology. 89:771–775. 2017.

38. Fenoy AJ, Simpson RK Jr. Risks of common complications in deep brain stimulation surgery: management and avoidance. J Neurosurg. 120:132–139. 2014.

39. Fishman PS, Frenkel V. Focused ultrasound: an emerging therapeutic modality for neurologic disease. Neurotherapeutics. 14:393–404. 2017.

40. Fomenko A, Neudorfer C, Dallapiazza RF, Kalia SK, Lozano AM. Lowintensity ultrasound neuromodulation: an overview of mechanisms and emerging human applications. Brain Stimul. 11:1209–1217. 2018.

41. Franklin ME, Foa EB. Treatment of obsessive compulsive disorder. Annu Rev Clin Psychol. 7:229–243. 2011.

42. Fry W. Neurosonic surgery. Trans Am Neurol Assoc (80th Meeting). 86–88. 1955.

43. Fry WJ. Intense ultrasound; a new tool for neurological research. J Ment Sci. 100:85–96. 1954.

44. Fry WJ, Mosberg WH Jr, Barnard JW, Fry FJ. Production of focal destructive lesions in the central nervous system with ultrasound. J Neurosurg. 11:471–478. 1954.

45. Fry WJ, Barnard JW, Fry FJ, Brennan JF. Ultrasonically produced localized selective lesions in the central nervous system. Am J Phys Med. 34:413–423. 1955.

46. Hsu PH, Wei KC, Huang CY, Wen CJ, Yen TC, Liu CL, et al. Noninvasive and targeted gene delivery into the brain using microbubble-facilitated focused ultrasound. PLoS One. 8:e57682. 2013.

47. Huisman M, van den Bosch MA. MR-guided high-intensity focused ultrasound for noninvasive cancer treatment. Cancer Imaging. 11:S161–S166. 2011.

48. Huss DS, Dallapiazza RF, Shah BB, Harrison MB, Diamond J, Elias WJ. Functional assessment and quality of life in essential tremor with bilateral or unilateral DBS and focused ultrasound thalamotomy. Mov Disord. 30:1937–1943. 2015.

49. Hynynen K, Jolesz FA. Demonstration of potential noninvasive ultrasound brain therapy through an intact skull. Ultrasound Med Biol. 24:275–283. 1998.

50. Hynynen K, McDannold N, Vykhodtseva N, Jolesz FA. Noninvasive MR imaging-guided focal opening of the blood-brain barrier in rabbits. Radiology. 220:640–646. 2001.

51. Hynynen K, McDannold N, Vykhodtseva N, Raymond S, Weissleder R, Jolesz FA, et al. Focal disruption of the blood-brain barrier due to 260-kHz ultrasound bursts: a method for molecular imaging and targeted drug delivery. J Neurosurg. 105:445–454. 2006.

52. Intemann PM, Masterman D, Subramanian I, DeSalles A, Behnke E, Frysinger R, et al. Staged bilateral pallidotomy for treatment of Parkinson disease. J Neurosurg. 94:437–444. 2001.

53. Jalali S, Huang Y, Dumont DJ, Hynynen K. Focused ultrasound-mediated bbb disruption is associated with an increase in activation of AKT: experimental study in rats. BMC Neurol. 10:114. 2010.

54. Jeanmonod D, Werner B, Morel A, Michels L, Zadicario E, Schiff G, et al. Transcranial magnetic resonance imaging-guided focused ultrasound: noninvasive central lateral thalamotomy for chronic neuropathic pain. Neurosurg Focus. 32:E1. 2012.

55. Johns LD. Nonthermal effects of therapeutic ultrasound: the frequency resonance hypothesis. J Athl Train. 37:293–299. 2002.

56. Jordão JF, Ayala-Grosso CA, Markham K, Huang Y, Chopra R, McLaurin J, et al. Antibodies targeted to the brain with image-guided focused ultrasound reduces amyloid-beta plaque load in the TgCRND8 mouse model of Alzheimer’s disease. PLoS One. 5:e10549. 2010.

57. Jordão JF, Thévenot E, Markham-Coultes K, Scarcelli T, Weng YQ, Xhima K, et al. Amyloid-beta plaque reduction, endogenous antibody delivery and glial activation by brain-targeted, transcranial focused ultrasound. Exp Neurol. 248:16–29. 2013.

58. Jung HH, Kim SJ, Roh D, Chang JG, Chang WS, Kweon EJ, et al. Bilateral thermal capsulotomy with MR-guided focused ultrasound for patients with treatment-refractory obsessive-compulsive disorder: a proof-ofconcept study. Mol Psychiatry. 20:1205–1211. 2015.

59. Kang JY, Wu C, Tracy J, Lorenzo M, Evans J, Nei M, et al. Laser interstitial thermal therapy for medically intractable mesial temporal lobe epilepsy. Epilepsia. 57:325–334. 2016.

60. Kelly D. Psychosurgery and the limbic system. Postgrad Med J. 49:825–833. 1973.

61. Kennedy JE. High-intensity focused ultrasound in the treatment of solid tumours. Nat Rev Cancer. 5:321–327. 2005.

62. Kim M, Kim CH, Jung HH, Kim SJ, Chang JW. Treatment of major depressive disorder via magnetic resonance-guided focused ultrasound surgery. Biol Psychiatry. 83:e17–e18. 2018.

63. Kim SJ, Roh D, Jung HH, Chang WS, Kim CH, Chang JW. A study of novel bilateral thermal capsulotomy with focused ultrasound for treatment-refractory obsessive-compulsive disorder: 2-year follow-up. J Psychiatry Neurosci. 43:170188. 2018.

64. Kinoshita M, McDannold N, Jolesz FA, Hynynen K. Noninvasive localized delivery of Herceptin to the mouse brain by MRI-guided focused ultrasound-induced blood-brain barrier disruption. Proc Natl Acad Sci U S A. 103:11719–11723. 2006.

65. Kinoshita M, McDannold N, Jolesz FA, Hynynen K. Targeted delivery of antibodies through the blood-brain barrier by MRI-guided focused ultrasound. Biochem Biophys Res Commun. 340:1085–1090. 2006.

66. Kovacs Z, Werner B, Rassi A, Sass JO, Martin-Fiori E, Bernasconi M. Prolonged survival upon ultrasound-enhanced doxorubicin delivery in two syngenic glioblastoma mouse models. J Control Release. 187:74–82. 2014.

67. Lee MS, Marsden CD. Movement disorders following lesions of the thalamus or subthalamic region. Mov Disord. 9:493–507. 1994.

68. Lee W, Kim H, Jung Y, Song IU, Chung YA, Yoo SS. Image-guided transcranial focused ultrasound stimulates human primary somatosensory cortex. Sci Rep. 5:8743. 2015.

69. Leinenga G, Götz J. Scanning ultrasound removes amyloid-β and restores memory in an Alzheimer’s disease mouse model. Sci Transl Med 7. 278ra233:2015.

70. Li L, Xu B, Zhu Y, Chen L, Sokabe M, Chen L. DHEA prevents Abeta25-35-impaired survival of newborn neurons in the dentate gyrus through a modulation of PI3K-Akt-mTOR signaling. Neuropharmacology. 59:323–333. 2010.

71. Lipsman N, Meng Y, Bethune AJ, Huang Y, Lam B, Masellis M, et al. Blood-brain barrier opening in Alzheimer’s disease using MR-guided focused ultrasound. Nat Commun. 9:2336. 2018.

72. Lipsman N, Schwartz ML, Huang Y, Lee L, Sankar T, Chapman M, et al. MR-guided focused ultrasound thalamotomy for essential tremor: a proof-of-concept study. Lancet Neurol. 12:462–468. 2013.

73. Liu HL, Hua MY, Chen PY, Chu PC, Pan CH, Yang HW, et al. Bloodbrain barrier disruption with focused ultrasound enhances delivery of chemotherapeutic drugs for glioblastoma treatment. Radiology. 255:415–425. 2010.

74. Liu HL, Hua MY, Yang HW, Huang CY, Chu PC, Wu JS, et al. Magnetic resonance monitoring of focused ultrasound/magnetic nanoparticle targeting delivery of therapeutic agents to the brain. Proc Natl Acad Sci U S A. 107:15205–15210. 2010.

75. MacDonell J, Patel N, Rubino S, Ghoshal G, Fischer G, Burdette EC, et al. Magnetic resonance-guided interstitial high-intensity focused ultrasound for brain tumor ablation. Neurosurg Focus. 44:E11. 2018.

76. Magara A, Bühler R, Moser D, Kowalski M, Pourtehrani P, Jeanmonod D. First experience with MR-guided focused ultrasound in the treatment of Parkinson’s disease. J Ther Ultrasound. 2:11. 2014.

77. Martínez-Fernández R, Rodríguez-Rojas R, Del Álamo M, Hernández-Fernández F, Pineda-Pardo JA, Dileone M, et al. Focused ultrasound subthalamotomy in patients with asymmetric Parkinson’s disease: a pilot study. Lancet Neurol. 17:54–63. 2018.

78. McDannold N, Arvanitis CD, Vykhodtseva N, Livingstone MS. Temporary disruption of the blood-brain barrier by use of ultrasound and microbubbles: safety and efficacy evaluation in rhesus macaques. Cancer Res. 72:3652–3663. 2012.

79. McDannold N, Clement GT, Black P, Jolesz F, Hynynen K. Transcranial magnetic resonance imaging- guided focused ultrasound surgery of brain tumors: initial findings in 3 patients. Neurosurgery. 66:323–332. discussion 332. 2010.

80. McDannold N, Vykhodtseva N, Raymond S, Jolesz FA, Hynynen K. MRIguided targeted blood-brain barrier disruption with focused ultrasound: histological findings in rabbits. Ultrasound Med Biol. 31:1527–1537. 2005.

81. McDannold NJ, Vykhodtseva NI, Hynynen K. Microbubble contrast agent with focused ultrasound to create brain lesions at low power levels: MR imaging and histologic study in rabbits. Radiology. 241:95–106. 2006.

82. Meng Y, Suppiah S, Mithani K, Solomon B, Schwartz ML, Lipsman N. Current and emerging brain applications of MR-guided focused ultrasound. J Ther Ultrasound. 5:26. 2017.

83. Meyers R, Fry WJ, Fry FJ, Dreyer LL, Schultz DF, Noyes RF. Early experiences with ultrasonic irradiation of the pallidofugal and nigral complexes in hyperkinetic and hypertonic disorders. J Neurosurg. 16:32–54. 1959.

84. Monteith S, Sheehan J, Medel R, Wintermark M, Eames M, Snell J, et al. Potential intracranial applications of magnetic resonance-guided focused ultrasound surgery. J Neurosurg. 118:215–221. 2013.

85. Monteith SJ, Harnof S, Medel R, Popp B, Wintermark M, Lopes MB, et al. Minimally invasive treatment of intracerebral hemorrhage with magnetic resonance-guided focused ultrasound. J Neurosurg. 118:1035–1045. 2013.

86. Morris CE, Juranka PF. Nav channel mechanosensitivity: activation and inactivation accelerate reversibly with stretch. Biophys J. 93:822–833. 2007.

87. Na YC, Chang WS, Jung HH, Kweon EJ, Chang JW. Unilateral magnetic resonance-guided focused ultrasound pallidotomy for Parkinson disease. Neurology. 85:549–551. 2015.

88. Naor O, Krupa S, Shoham S. Ultrasonic neuromodulation. J Neural Eng. 13:031003. 2016.

89. Niranjan A, Raju SS, Kooshkabadi A, Monaco E 3rd, Flickinger JC, Lunsford LD. Stereotactic radiosurgery for essential tremor: retrospective analysis of a 19-year experience. Mov Disord. 32:769–777. 2017.

90. Niu J, Xie J, Guo K, Zhang X, Xia F, Zhao X, et al. Efficient treatment of Parkinson’s disease using ultrasonography-guided rhFGF20 proteoliposomes. Drug Deliv. 25:1560–1569. 2018.

91. Nyborg WL. Acoustic streaming. San Diego: Academic Press;1998. p. p207.

92. O’Brien WD Jr. Ultrasound-biophysics mechanisms. Prog Biophys Mol Biol. 93:212–255. 2007.

93. Pardridge WM. Blood-brain barrier drug targeting: the future of brain drug development. Mol Interv. 3:90–105. 151, 2003.

94. Pardridge WM. The blood-brain barrier: bottleneck in brain drug development. NeuroRx. 2:3–14. 2005.

95. Park EJ, Zhang YZ, Vykhodtseva N, McDannold N. Ultrasound-mediated blood-brain/blood-tumor barrier disruption improves outcomes with trastuzumab in a breast cancer brain metastasis model. J Control Release. 163:277–284. 2012.

96. Patel DM, Walker HC, Brooks R, Omar N, Ditty B, Guthrie BL. Adverse events associated with deep brain stimulation for movement disorders: analysis of 510 consecutive cases. Neurosurgery 11 Suppl. 2:190–199. 2015.

97. Ravikumar VK, Parker JJ, Hornbeck TS, Santini VE, Pauly KB, Wintermark M, et al. Cost-effectiveness of focused ultrasound, radiosurgery, and DBS for essential tremor. Mov Disord. 32:1165–1173. 2017.

98. Raymond SB, Treat LH, Dewey JD, McDannold NJ, Hynynen K, Bacskai BJ. Ultrasound enhanced delivery of molecular imaging and therapeutic agents in Alzheimer’s disease mouse models. PLoS One. 3:e2175. 2008.

99. Reher P, Doan N, Bradnock B, Meghji S, Harris M. Effect of ultrasound on the production of IL-8, basic FGF and VEGF. Cytokine. 11:416–423. 1999.

100. Rezayat E, Toostani IG. A review on brain stimulation using low intensity focused ultrasound. Basic Clin Neurosci. 7:187–194. 2016.

101. Scarcelli T, Jordão JF, O’Reilly MA, Ellens N, Hynynen K, Aubert I. Stimulation of hippocampal neurogenesis by transcranial focused ultrasound and microbubbles in adult mice. Brain Stimul. 7:304–307. 2014.

102. Schlesinger I, Eran A, Sinai A, Erikh I, Nassar M, Goldsher D, et al. MRI guided focused ultrasound thalamotomy for moderate-to-severe tremor in Parkinson’s disease. Parkinsons Dis. 2015:219149. 2015.

103. Scoville WB. Selective cortical undercutting as a means of modifying and studying frontal lobe function in man; preliminary report of 43 operative cases. J Neurosurg. 6:65–73. 1949.

104. Sheikov N, McDannold N, Sharma S, Hynynen K. Effect of focused ultrasound applied with an ultrasound contrast agent on the tight junctional integrity of the brain microvascular endothelium. Ultrasound Med Biol. 34:1093–1104. 2008.

105. Sheikov N, McDannold N, Vykhodtseva N, Jolesz F, Hynynen K. Cellular mechanisms of the blood-brain barrier opening induced by ultrasound in presence of microbubbles. Ultrasound Med Biol. 30:979–989. 2004.

106. Shung KK, Smith M, Tsui BMW. Principles of Medical Imaging. Oxford: Elsevier Science;1992.

107. Siegel KL, Metman LV. Effects of bilateral posteroventral pallidotomy on gait of subjects with Parkinson disease. Arch Neurol. 57:198–204. 2000.

108. Sillay KA, Larson PS, Starr PA. Deep brain stimulator hardware-related infections: incidence and management in a large series. Neurosurgery. 62:360–366. discussion 366-367. 2008.

109. Sprawls P. Physical Principles of Medical Imaging. Rockville: Aspen;1987.

110. Szabo T. Diagnostic Ultrasound Imaging Inside Out. Amsterdam: Elsevier Academic;2004.

111. Tasker RR. Deep brain stimulation is preferable to thalamotomy for tremor suppression. Surg Neurol. 49:145–153. discussion 153-154. 1998.

112. ter Haar G. Therapeutic applications of ultrasound. Prog Biophys Mol Biol. 93:111–129. 2007.

113. Thévenot E, Jordão JF, O’Reilly MA, Markham K, Weng YQ, Foust KD, et al. Targeted delivery of self-complementary adeno-associated virus serotype 9 to the brain, using magnetic resonance imaging-guided focused ultrasound. Hum Gene Ther. 23:1144–1155. 2012.

114. Timbie KF, Afzal U, Date A, Zhang C, Song J, Wilson Miller G, et al. MR image-guided delivery of cisplatin-loaded brain-penetrating nanoparticles to invasive glioma with focused ultrasound. J Control Release. 263:120–131. 2017.

115. Treat LH, McDannold N, Vykhodtseva N, Zhang Y, Tam K, Hynynen K. Targeted delivery of doxorubicin to the rat brain at therapeutic levels using MRI-guided focused ultrasound. Int J Cancer. 121:901–907. 2007.

116. Treat LH, McDannold N, Zhang Y, Vykhodtseva N, Hynynen K. Improved anti-tumor effect of liposomal doxorubicin after targeted blood-brain barrier disruption by MRI-guided focused ultrasound in rat glioma. Ultrasound Med Biol. 38:1716–1725. 2012.

117. Tufail Y, Matyushov A, Baldwin N, Tauchmann ML, Georges J, Yoshihiro A, et al. Transcranial pulsed ultrasound stimulates intact brain circuits. Neuron. 66:681–694. 2010.

118. Tyler WJ. Noninvasive neuromodulation with ultrasound? A continuum mechanics hypothesis. Neuroscientist. 17:25–36. 2011.

119. Tyler WJ, Tufail Y, Finsterwald M, Tauchmann ML, Olson EJ, Majestic C. Remote excitation of neuronal circuits using low-intensity, low-frequency ultrasound. PLoS One. 3:e3511. 2008.

120. Vykhodtseva N, McDannold N, Hynynen K. Progress and problems in the application of focused ultrasound for blood-brain barrier disruption. Ultrasonics. 48:279–296. 2008.

121. Vykhodtseva NI, Hynynen K, Damianou C. Histologic effects of high intensity pulsed ultrasound exposure with subharmonic emission in rabbit brain in vivo. Ultrasound Med Biol. 21:969–979. 1995.

122. Wei KC, Chu PC, Wang HY, Huang CY, Chen PY, Tsai HC, et al. Focused ultrasound-induced blood-brain barrier opening to enhance temozolomide delivery for glioblastoma treatment: a preclinical study. PLoS One. 8:e58995. 2013.

123. Weigel R, Krauss JK. Center median-parafascicular complex and pain control. Review from a neurosurgical perspective. Stereotact Funct Neurosurg. 82:115–126. 2004.

124. Yang FY, Wong TT, Teng MC, Liu RS, Lu M, Liang HF, et al. Focused ultrasound and interleukin-4 receptor-targeted liposomal doxorubicin for enhanced targeted drug delivery and antitumor effect in glioblastoma multiforme. J Control Release. 160:652–658. 2012.

125. Yao L, Song Q, Bai W, Zhang J, Miao D, Jiang M, et al. Facilitated brain delivery of poly (ethylene glycol)-poly (lactic acid) nanoparticles by microbubble-enhanced unfocused ultrasound. Biomaterials. 35:3384–3395. 2014.

126. Young RF, Vermeulen SS, Grimm P, Posewitz AE, Jacques DB, Rand RW, et al. Gamma Knife thalamotomy for the treatment of persistent pain. Stereotact Funct Neurosurg 64 Suppl. 1:172–181. 1995.

127. Yu H, Neimat JS. The treatment of movement disorders by deep brain stimulation. Neurotherapeutics. 5:26–36. 2008.

128. Zaaroor M, Sinai A, Goldsher D, Eran A, Nassar M, Schlesinger I. Magnetic resonance-guided focused ultrasound thalamotomy for tremor: a report of 30 Parkinson’s disease and essential tremor cases. J Neurosurg. 128:202–210. 2018.